Log In
BCIQ
Print this Print this
 

Anaplastic lymphoma kinase (ALK)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Anaplastic lymphoma kinase (ALK)

BCIQ
Print ChartPrint this
1 5 2 2 3
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase IIMarketed
Cancer

1

5

2

2

3




 Products Targeting Anaplastic lymphoma kinase (ALK)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

13

$2,878.4M

$1.4M

$27.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today